| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/11/2003 | US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases |
| 09/11/2003 | US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/11/2003 | US20030171354 Indole derivatives |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. |
| 09/11/2003 | US20030171267 Albumin fusion proteins |
| 09/11/2003 | US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 09/11/2003 | US20030170840 Genomic mammary amyloid a sequence |
| 09/11/2003 | US20030170685 Canine hepatocyte growth factor |
| 09/11/2003 | US20030170300 Combination chemotherapy |
| 09/11/2003 | US20030170286 Codrug with at least two constituent moieties cleavably linked covalently to one another; dimensioned to position two radiation seeds a predetermined distance apart. |
| 09/11/2003 | US20030170220 For inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia |
| 09/11/2003 | US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood |
| 09/10/2003 | EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 09/10/2003 | EP1342717A1 Benzimidazole derivatives |
| 09/10/2003 | EP1341817A2 Tff peptides |
| 09/10/2003 | EP1341777A2 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatement of incontinence |
| 09/10/2003 | EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 09/10/2003 | EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 09/10/2003 | EP1341754A1 Substituted anthranilic acids |
| 09/10/2003 | EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/10/2003 | EP1341529A2 Hydrolytically unstable compositions |
| 09/10/2003 | EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 09/10/2003 | EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 09/10/2003 | EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 09/10/2003 | CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 09/10/2003 | CN1441803A Indoloquinazolinones |
| 09/10/2003 | CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 09/10/2003 | CN1441791A 四唑衍生物 Tetrazole derivative |
| 09/10/2003 | CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues |
| 09/10/2003 | CN1441783A Medicine comprising dicyanopyridine derivative |
| 09/10/2003 | CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 09/10/2003 | CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 09/10/2003 | CN1441779A Proline derivatives and use thereof as drugs |
| 09/10/2003 | CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 09/10/2003 | CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists |
| 09/10/2003 | CN1441770A Modified forms of pharmacologically active agents and uses therefor |
| 09/10/2003 | CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors |
| 09/10/2003 | CN1440778A Kidney invigorating Chinese medicine |
| 09/09/2003 | US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 09/09/2003 | US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides |
| 09/09/2003 | US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 09/09/2003 | US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders |
| 09/09/2003 | US6617324 Substituted pyrazoles as p38 kinase inhibitors |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/09/2003 | US6616943 Composition comprising Wenguanguo extracts and methods for preparing same |
| 09/09/2003 | CA2269031C Treatment of urinary incontinence and compositions for use therein |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2248953C Novel benzofuranone derivatives and process for producing the same |
| 09/09/2003 | CA2142121C Effects of actin filaments on fibrin clot structure and lysis |
| 09/04/2003 | WO2003073107A2 Neuropeptide receptor and uses thereof |
| 09/04/2003 | WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/04/2003 | WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/04/2003 | WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/04/2003 | WO2003072577A1 Thiazole derivatives as npy receptor antagonists |
| 09/04/2003 | WO2003072572A1 Beta3-adrenergic receptor agonists |
| 09/04/2003 | WO2003072570A1 Antidiabetic agents |
| 09/04/2003 | WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 09/04/2003 | WO2003072566A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 09/04/2003 | WO2003072561A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/04/2003 | WO2003072558A2 Arylsulfone derivatives |
| 09/04/2003 | WO2003072550A1 Novel fused ring indazole compounds |
| 09/04/2003 | WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | WO2003072123A1 Stabilized albumin preparaions |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents |
| 09/04/2003 | WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors |
| 09/04/2003 | WO2003045313A3 2-aminoquinoline compounds |
| 09/04/2003 | WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 09/04/2003 | WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/04/2003 | WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors |
| 09/04/2003 | WO2001081622A3 Diagnosis of diseases associated with dna repair |
| 09/04/2003 | WO2001076451A3 Diagnosis of diseases associated with metabolism |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2003 | US20030167525 Desaturase genes and uses thereof |
| 09/04/2003 | US20030167033 Systems and methods for photodynamic therapy |
| 09/04/2003 | US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 09/04/2003 | US20030166910 Bone morphogenic protein |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 09/04/2003 | US20030166652 Chemical compounds |
| 09/04/2003 | US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases |
| 09/04/2003 | US20030166633 Pyridinylimidazoles |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030165892 Unigene unidirectional antisense library |
| 09/04/2003 | CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| 09/04/2003 | CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |